Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Gene Therapy00:59

Gene Therapy

4.5K
4.5K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory Meetings.

Human gene therapy·2026
Same author

Developing therapeutics for rare cardiovascular diseases.

American heart journal·2025
Same author

Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program.

Human gene therapy·2025
Same author

Simultaneous targeting of B-cell malignancies and human immunodeficiency virus with bispecific chimeric antigen receptor T cells.

Haematologica·2024
Same author

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.

Communications medicine·2024
Same author

HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.

The New England journal of medicine·2024

Related Experiment Video

Updated: May 3, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.0K

Practical considerations in gene therapy for HIV cure.

Rodica Stan1, John A Zaia

  • 1Department of Virology, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA.

Current HIV/AIDS Reports
|January 23, 2014
PubMed
Summary

Gene therapy offers a potential cure for HIV-1 infection, overcoming limitations of current antiretroviral therapy. Challenges include safety, clinical trial design, and cost, which are discussed in current gene therapy studies.

More Related Videos

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

10.8K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K

Related Experiment Videos

Last Updated: May 3, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.0K
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

10.8K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K

Area of Science:

  • Immunology
  • Virology
  • Biotechnology

Background:

  • Antiretroviral therapy (ART) effectively suppresses HIV-1 but has limitations including long-term side effects, lifelong commitment, and high costs.
  • Non-AIDS related comorbidities and mortality remain significant concerns for individuals on ART.
  • Gene therapy presents a promising alternative for potentially eradicating HIV-1 infection.

Purpose of the Study:

  • To review the potential of gene therapy as a curative strategy for HIV-1 infection.
  • To discuss the challenges and concerns associated with implementing gene therapy for HIV/AIDS.
  • To analyze the current landscape of gene therapy studies in HIV/AIDS.

Main Methods:

  • Review of existing literature on gene therapy for HIV/AIDS.
  • Analysis of key challenges including applicability, safety of conditioning, clinical trial design, cell selection, and manufacturing costs.
  • Discussion of relevant gene therapy studies conducted to date.

Main Results:

  • Gene therapy holds significant promise for HIV-1 eradication.
  • Several critical concerns must be addressed for successful clinical application.
  • Ongoing research and clinical trials are essential to overcome these hurdles.

Conclusions:

  • Gene therapy is a viable future option for curing HIV-1 infection.
  • Addressing safety, cost, and logistical challenges is paramount for widespread adoption.
  • Continued research is crucial to translate gene therapy potential into clinical reality for HIV/AIDS patients.